Meersch Melanie, Schmidt Christoph, Zarbock Alexander
Department of Anesthesiology, Intensive Care and Pain Medicine, University of Muenster, Muenster, Germany.
Curr Opin Anaesthesiol. 2016 Jun;29(3):413-20. doi: 10.1097/ACO.0000000000000329.
Chronic kidney disease (CKD) is an increasing health problem worldwide and is associated with a number of clinical challenges. In this paper, we review recent studies that deal with strategies for the management of patients with CKD undergoing surgery.
Effective strategies for nephroprotection are crucial for the handling of patients with CKD in the perioperative setting to prevent complications and to avoid the progression of CKD. Due to the lack of perioperative studies with CKD patients there are only level 2 recommendations. First of all, this requires the identification of CKD patients through risk assessment and preoperative laboratory tests. In this regard, biomarkers, such as cystatin C may facilitate the detection of chronically impaired renal function. Secondly, particular attention should be paid to the maintenance of hemodynamic stability, including an adequate blood pressure and cardiac index and the preservation of intravascular volume. There is clear evidence that an unimpaired renal perfusion, guaranteed through hemodynamic stability, and an undisturbed fluid balance both reduce the incidence of acute kidney injury (AKI) and consequently the further deterioration of renal function. Thirdly, several studies demonstrate that tight glycemic control is associated with less renal impairment and better survival for patients with CKD. Lastly, the highest priority for the patient with CKD should be assigned to the prevention of AKI, which is an action of proven efficacy.
Identification and risk stratification is crucial for the perioperative management of patients with CKD. To improve clinical outcomes, nonemergent procedures should be postponed, renal function optimized, nephrotoxic drugs avoided, and AKI prevented.
慢性肾脏病(CKD)在全球范围内是一个日益严重的健康问题,并且与许多临床挑战相关。在本文中,我们回顾了近期关于CKD患者手术管理策略的研究。
有效的肾脏保护策略对于围手术期处理CKD患者以预防并发症和避免CKD进展至关重要。由于缺乏针对CKD患者的围手术期研究,仅有2级推荐。首先,这需要通过风险评估和术前实验室检查来识别CKD患者。在这方面,诸如胱抑素C等生物标志物可能有助于检测慢性肾功能受损。其次,应特别注意维持血流动力学稳定,包括适当的血压和心脏指数以及保持血管内容量。有明确证据表明,通过血流动力学稳定保证的未受损肾灌注和未受干扰的液体平衡均可降低急性肾损伤(AKI)的发生率,从而减少肾功能的进一步恶化。第三,多项研究表明,严格的血糖控制与CKD患者较少的肾功能损害和更好的生存率相关。最后,对于CKD患者,最高优先级应给予预防AKI,这是一种已证实有效的措施。
识别和风险分层对于CKD患者的围手术期管理至关重要。为改善临床结局,非急诊手术应推迟,肾功能应优化,应避免使用肾毒性药物,并预防AKI。